Metabolic Engineering and Biosynthetic Pathway Optimization
作者
Archana Jain,Surendra Sarsaiya,Qihai Gong
出处
期刊:CABI eBooks [CABI] 日期:2026-03-31卷期号:: 107-131
标识
DOI:10.1079/9781836994206.0004
摘要
Metabolic engineering and biosynthetic pathway optimization are pivotal strategies for enhancing the production of plant-derived secondary metabolites, such as alkaloids and terpenoids, which hold significant pharmaceutical and industrial value. This chapter explores methodologies, including pathway reconstruction, gene manipulation, and heterologous expression in microbial hosts, to overcome low yields inherent in native plant systems. Advanced tools like metabolic flux analysis (MFA) and flux balance analysis (FBA) enable precise quantification and optimization of metabolic fluxes, guiding pathway engineering for compounds like paclitaxel (Taxol) and artemisinin. Enzyme engineering, particularly of cytochrome P450s, is emphasized for diversifying metabolite structures and improving catalytic efficiency. Case studies highlight scalable biomanufacturing approaches, such as Taxus cell cultures for Paclitaxel production and microbial systems engineered via synthetic biology for terpenoid synthesis. Despite progress, challenges persist, including metabolic burden, enzyme promiscuity, and cost-effectiveness in industrial scaling. Omics technologies and machine learning offer data-driven solutions to unravel pathway complexity and predict optimal designs. Future directions focus on integrating multi-omics data, refining host compatibility, and advancing sustainable production systems. By addressing technical hurdles and leveraging interdisciplinary innovations, metabolic engineering promises to revolutionize the sustainable, high-yield production of bioactive plant metabolites for therapeutic and industrial applications.